Pasar al contenido principal

IDENTIFICACION DE VULNERABILIDADES EN MYCOBACTERIUM TUBERCULOSIS A TRAVES DE LA DISECCION GENETICA Y QUIMICA DEL PROCESO DE VESICULACION

PID2022-136611OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Protection and diagnostic interference induced by heat-inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis

  • Fernández Veiga, Leire
  • Fuertes Franco, Miguel
  • Geijo, María V.
  • Elguezabal, Natalia
  • Serrano Mestre, José Luis
  • Vázquez Iniesta, Lucía
  • Prados Rosales, Rafael
  • Michelet, Lorraine
  • Boschiroli, Maria Laura
  • Pérez de Val, Bernat
  • Jones, Gareth J.
  • Juste, Ramón A.
  • Garrido, Joseba M.
  • Sevilla, Iker A.
Introduction: Vaccination emerges as a promising cost-effective tool to reduce the impact and spread of animal tuberculosis, especially in regions where test-and-slaughter eradication strategy is socioeconomically unfeasible or unfruitful for different reasons, provided it is safe, efficacious and compatible with diagnosis. Methods: In this study, we preliminarily evaluated the diagnostic interference (using guinea pigs) and the protective efficacy (using mice) of three heat-inactivated, three phage-inactivated and one live attenuated vaccine prototypes prepared from M. bovis, M. caprae, and M. microti. Results and discussion: Phage-inactivation killed almost all (96.41–99.92%) bacteria to be included in vaccines and filtering was used to remove the remaining viable cells. All the assayed vaccines induced skin test reactions in response to bovine tuberculin, but they were smaller in the phage-inactivated vaccine groups. All the vaccines were diagnosis-compatible with defined skin test antigens based on ESAT-6, CFP-10, and Rv3615c. In contrast with the rest of prototypes, vaccination with heat- and phage-inactivated M. microti did not prompt the production of detectable anti-MPB70+MPB83 antibodies. Mean bacterial burden was lower in all vaccinated groups in comparison with the control, being significantly reduced in the lungs of the heat-inactivated M. microti and M. caprae and phage-inactivated M. caprae groups. Considering both diagnostic interference and protection collectively, the heat-inactivated M. microti vaccine showed the best performance. Further studies to evaluate these vaccines and to improve phage-driven inactivation are warranted, SI, The author(s) declare that financial support was received for the research and/or publication of this article. This study has been carried out with funds from Grants PID2019- 105155RB-C33 and PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by ERDF/EU, and Grant EFA115/01 INNOTUB II funded by the INTERREG POCTEFA 2021–2027 Program (co-funded by the European Union). LF-V holds a pre-doctoral fellowship from the Department of Economic Development, Sustainability and Environment of the Basque Government. RP-R thanks support from grants NIH RO1AI162821 and Spanish MICINN contracts PID2019-110240RB-I00 and PID2022-136611OB-I00
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Protection and diagnostic interference induced by heat-inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis

  • Fernández Veiga, Leire
  • Fuertes, Miguel
  • Geijo, María V.
  • Elguezabal, Natalia
  • Serrano-Mestre, Jose L.
  • Vázquez-Iniesta, Lucía
  • Prados-Rosales, Rafael
  • Michelet, Lorraine
  • Boschiroli, Maria Laura
  • Pérez de Val, Bernat
  • Jones, Gareth J.
  • Juste, Ramón A.
  • Garrido, Joseba M.
  • Sevilla, Iker A.
Introduction: Vaccination emerges as a promising cost-eective tool to reduce the impact and spread of animal tuberculosis, especially in regions where testand-slaughter eradication strategy is socioeconomically unfeasible or unfruitful for dierent reasons, provided it is safe, e cacious and compatible with diagnosis. Methods: In this study, we preliminarily evaluated the diagnostic interference (using guinea pigs) and the protective e cacy (using mice) of three heatinactivated, three phage-inactivated and one live attenuated vaccine prototypes prepared from M. bovis, M. caprae, and M. microti. Results and discussion: Phage-inactivation killed almost all (96.41–99.92%) bacteria to be included in vaccines and filtering was used to remove the remaining viable cells. All the assayed vaccines induced skin test reactions in response to bovine tuberculin, but they were smaller in the phage-inactivated vaccine groups. All the vaccines were diagnosis-compatible with defined skin test antigens based on ESAT-6, CFP-10, and Rv3615c. In contrast with the rest of prototypes, vaccination with heat- and phage-inactivated M. microti did not prompt the production of detectable anti-MPB70+MPB83 antibodies. Mean bacterial burden was lower in all vaccinated groups in comparison with the control, being significantly reduced in the lungs of the heat-inactivated M. microti and M. caprae and phage-inactivated M. caprae groups. Considering both diagnostic interference and protection collectively, the heat-inactivated M. microti vaccine showed the best performance. Further studies to evaluate these vaccines and to improve phage-driven inactivation are warranted., The author(s) declare that financial support was received for the research and/or publication of this article. This study has been carried out with funds from Grants PID2019-105155RB-C33 and PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by ERDF/EU, and Grant EFA115/01 INNOTUB II funded by the INTERREG POCTEFA 2021–2027 Program (co-funded by the European Union). LF-V holds a pre-doctoral fellowship from the Department of Economic Development, Sustainability and Environment of the Basque Government. RP-R thanks support from grants NIH RO1AI162821 and Spanish MICINN contracts PID2019-110240RB-I00 and PID2022-136611OB-I00., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Maintenance of cell wall remodeling and vesicle production are connected in Mycobacterium tuberculosis

  • Salgueiro-Toledo, Vivian C.
  • Bertol, Jorge
  • Gutierrez, Claude
  • Serrano-Mestre, Jose L.
  • Ferrer-Luzon, Noelia
  • Vázquez-Iniesta, Lucía
  • Palacios, Ainhoa
  • Pasquina Lemonche, Laia
  • Espaillat, Akbar
  • Lerma, Laura
  • Weinrick, Brian
  • Lavín, José Luis
  • Elortza, Félix
  • Azkargorta, Mikel
  • Prieto Orzanco, Alicia
  • Buendía-Nacarino, Pilar
  • Luque-García, José Luis
  • Neyrolles, Olivier
  • Cava, Felipe
  • Hobbs, Jamie K.
  • Sanz, Joaquín
  • Prados-Rosales, Rafael
38 p.-9 fig., Pathogenic and nonpathogenic mycobacteria secrete extracellular vesicles (EVs) under various conditions. EVs produced by Mycobacterium tuberculosis (Mtb) have raised significant interest for their potential in cell communication, nutrient acquisition, and immune evasion. However, the relevance of vesicle secretion during tuberculosis infection remains unknown due to the limited understanding of mycobacterial vesicle biogenesis. We have previously shown that a transposon mutant in the LCP-related gene virR (virRmut) manifested a strong attenuated phenotype during experimental macrophage and murine infections, concomitant to enhanced vesicle release. In this study, we aimed to understand the role of VirR in the vesicle production process in Mtb. We employ genetic, transcriptional, proteomics, ultrastructural, and biochemical methods to investigate the underlying processes explaining the enhanced vesiculogenesis phenomenon observed in the virRmut. Our results establish that VirR is critical to sustain proper cell permeability via regulation of cell envelope remodeling possibly through the interaction with similar cell envelope proteins, which control the link between peptidoglycan and arabinogalactan. These findings advance our understanding of mycobacterial extracellular vesicle biogenesis and suggest that these set of proteins could be attractive targets for therapeutic intervention., RP-R acknowledges support by MINECO/FEDER EU contracts SAF2016–77433-R,PID2019-110240RB- I00,PID2022-136611OB-I00;and NIH-R01AI162821.CICbioGUNE thanks MINECO for the Severo Ochoa Excellence Accreditation (SEV-2016–0644). LP-L and JKH acknowledges support by the Wellcome Trust (212197/Z/19/Z) which funded part of this research. For the purpose of open access, the authors have applied and will apply a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. JS acknowledges support from the Spanish Ministry of Science and Innovation (MICINN) through grant PID2019-106859GA-I00 and Ramón y Cajal research grant RYC-2017-23560,as well as to the Government of Aragón, Spain,through grant B49-23R (NeuroBioSys). FC lab research is supported by the Swedish Research Council (VR2018-02823 and VR2018-05882), the Laboratory for Molecular Infection Medicine Sweden (MIMS),Umeå University, the Knut and Alice Wallenberg Foundation (KAW) grant KAW2012.0184 and the Kempe Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The unique role of nucS-mediated noncanonical mismatch repair in Mycobacterium tuberculosis resistance evolution

  • Martín-Blecua, Isabel
  • Sastre-Domínguez, Jorge
  • Valverde, José R.
  • García-Bravo, Pablo
  • Ruíz Enamorado, Ángel
  • Prados-Rosales, Rafael
  • Das, Lahari
  • Jacobs, William R
  • San Millán, Álvaro
  • Blázquez, Jesús
  • Gullón Blanco, Sonia
DNA surveillance mechanisms are crucial for maintaining genome stability and minimizing mutation rates. Mismatch repair (MMR) corrects replication errors that escape DNA-polymerase proofreading. In most organisms, MMR is orchestrated by MutS and MutL proteins. However, certain Archaea and Actinobacteria, including the major human pathogen Mycobacterium tuberculosis, lack these components. Instead, they appear to rely on the nuclease EndoMS/NucS, a structurally distinct enzyme governing a non-canonical MMR pathway. Since M. tuberculosis acquires drug resistance exclusively through chromosomal mutations, understanding its mutation rate regulation is critical. Nevertheless, the role of NucS in drug resistance evolution remains largely unexplored. We investigated NucS function in M. tuberculosis and uncovered a unique resistance dynamic distinct from other Actinobacteria. Deleting nucS altered the mutational spectrum but had minimal impact on the emergence of antibiotic-resistant mutants, contrasting sharply with other Actinobacteria where nucS loss dramatically increases mutation rates. This atypical behavior cannot be attributed solely to the R144S NucS polymorphism present in the H37Rv reference strain. Introducing the consensus NucS sequence in H37Rv produced only subtle changes in mutational spectrum without major effects on mutation rates. Analysis of 44,921 M. tuberculosis genomes revealed that most R144S-containing strains belong to the Euro-American sub-lineage 4.9, with no significant association with antibiotic resistance. However, nucS is under strong purifying selection, and R144S changes arose independently during M. tuberculosis evolution (homoplasy). Overall, our findings challenge the view that nucS serves as a genome stability guardian in M. tuberculosis and suggest additional mismatch repair mechanism(s) beyond NucS in this pathogen.IMPORTANCEDNA repair systems are crucial for maintaining the integrity of genetic information by scanning and correcting errors that arise during DNA replication. Most organisms use well-characterized proteins (MutS and MutL) for this task, but some bacteria and archaea, including most Actinobacteria, lack these conventional components. Instead, they employ an alternative enzyme, NucS, to fix replicative DNA errors. This alternative pathway is thought to limit harmful mutations and, in turn, reduce the likelihood of drug resistance development. In our study of Mycobacterium tuberculosis, the pathogen responsible for tuberculosis, we found that NucS plays only a minor role in preventing resistance-associated mutations. This unexpected result challenges current assumptions about DNA repair in this pathogen and points to the existence of other, yet unidentified mechanisms that safeguard its genome. Understanding these processes could open new avenues for therapeutic strategies against tuberculosis, a disease that remains a major global health threat., This research was supported by Ministerio de Ciencia (MCIN/AEI/10.13039/501100011033) (Grant PID2020-112865RB-I00). I.M.-B. was supported by the PRE2021-099108 grant, funded by MCIN/AEI/10.13039/501100011033 and the FSE+. A.S.M. and J.S.-D. were supported by the European Research Council (ERC) under the European Union’s Horizon Europe research and innovation program (ERC-2022-CoG Project 101086992–PLAS-FIGHTER). R.P.-R. acknowledges support by MINECO/FEDER EU contracts PID2022-136611OB-I00 and NIH-R01AI162821., Peer reviewed, Sin uso de modelos vivos
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Phagosomal RNA sensing through TLR8 controls susceptibility to tuberculosis

  • Maserumule, Charlotte
  • Passemar, Charlotte
  • Oh, Olivia S.H.
  • Hegyi, Kriztina
  • Brown, Karen
  • Weimann, Aaron
  • Dinan, Adam
  • Davila, Sonia
  • Klapholz, Catherine
  • Bryant, Josephine
  • Verma, Deepshikha
  • Gadwa, Jacob
  • Krishnananthasivam, Shivankari
  • Vongtongsalee, Kridakorn
  • Kendall, Edward
  • Trelles, Andres
  • Hibberd, Martin L.
  • Sanz, Joaquín
  • Bertol, Jorge
  • Vázquez-Iniesta, Lucia
  • Andi, Kaliappan
  • Kumar, S. Siva
  • Ordway, Diane
  • Prados-Rosales, Rafael
  • MacAry, Paul A.
  • Floto, R. Andres
Genetic determinants of susceptibility to Mycobacterium tuberculosis (Mtb) remain poorly understood but could provide insights into critical pathways involved in infection, informing host-directed therapies and enabling risk stratification at individual and population levels. Through a genome-wide forward genetic screen, we identify Toll-like receptor 8 (TLR8) as a key regulator of intracellular killing of Mtb. Pharmacological TLR8 activation enhances the killing of phylogenetically diverse clinical isolates of drug-susceptible and multidrug-resistant Mtb by macrophages and during in vivo infection in mice. TLR8 is activated by phagosomal mycobacterial RNA released by extracellular membrane vesicles and enhances xenophagy-dependent Mtb killing. We find that the TLR8 variant M1V, common in Far Eastern populations, enhances intracellular killing of Mtb through preferential signal-dependent trafficking to phagosomes. TLR8 signaling may, therefore, both regulate susceptibility to tuberculosis and provide novel drug targets.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Protection and diagnostic interference induced by heat-inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis

  • Fernández Veiga, Leire
  • Fuertes, Miguel
  • Geijo, María V.
  • Elguezabal, Natalia
  • Serrano-Mestre, Jose L.
  • Vázquez-Iniesta, Lucía
  • Prados-Rosales, Rafael
  • Michelet, Lorraine
  • Boschiroli, Maria Laura
  • Pérez de Val, Bernat
  • Jones, Gareth J.
  • Juste, Ramón A.
  • Garrido, Joseba M.
  • Sevilla, Iker A.
Introduction: Vaccination emerges as a promising cost-eective tool to reduce the impact and spread of animal tuberculosis, especially in regions where testand-slaughter eradication strategy is socioeconomically unfeasible or unfruitful for dierent reasons, provided it is safe, e cacious and compatible with diagnosis. Methods: In this study, we preliminarily evaluated the diagnostic interference (using guinea pigs) and the protective e cacy (using mice) of three heatinactivated, three phage-inactivated and one live attenuated vaccine prototypes prepared from M. bovis, M. caprae, and M. microti. Results and discussion: Phage-inactivation killed almost all (96.41–99.92%) bacteria to be included in vaccines and filtering was used to remove the remaining viable cells. All the assayed vaccines induced skin test reactions in response to bovine tuberculin, but they were smaller in the phage-inactivated vaccine groups. All the vaccines were diagnosis-compatible with defined skin test antigens based on ESAT-6, CFP-10, and Rv3615c. In contrast with the rest of prototypes, vaccination with heat- and phage-inactivated M. microti did not prompt the production of detectable anti-MPB70+MPB83 antibodies. Mean bacterial burden was lower in all vaccinated groups in comparison with the control, being significantly reduced in the lungs of the heat-inactivated M. microti and M. caprae and phage-inactivated M. caprae groups. Considering both diagnostic interference and protection collectively, the heat-inactivated M. microti vaccine showed the best performance. Further studies to evaluate these vaccines and to improve phage-driven inactivation are warranted., The author(s) declare that financial support was received for the research and/or publication of this article. This study has been carried out with funds from Grants PID2019-105155RB-C33 and PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by ERDF/EU, and Grant EFA115/01 INNOTUB II funded by the INTERREG POCTEFA 2021–2027 Program (co-funded by the European Union). LF-V holds a pre-doctoral fellowship from the Department of Economic Development, Sustainability and Environment of the Basque Government. RP-R thanks support from grants NIH RO1AI162821 and Spanish MICINN contracts PID2019-110240RB-I00 and PID2022-136611OB-I00., info:eu-repo/semantics/publishedVersion